Detalles de la búsqueda
1.
Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2-metastatic breast cancer receiving single-agent chemotherapy-a comparison with MONARCH 1.
Breast Cancer Res Treat
; 184(1): 161-172, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32789591
2.
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A Randomized Clinical Trial.
JAMA Oncol
; 6(1): 116-124, 2020 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31563959
3.
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE).
J Clin Oncol
; 38(34): 3987-3998, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32954927
4.
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer.
NPJ Breast Cancer
; 5: 5, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30675515
5.
Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy.
NPJ Breast Cancer
; 4: 41, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30588487
6.
MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2- Metastatic Breast Cancer.
Clin Cancer Res
; 23(17): 5218-5224, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28533223
7.
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer.
J Clin Oncol
; 35(32): 3638-3646, 2017 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28968163
8.
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy.
J Clin Oncol
; 35(25): 2875-2884, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28580882
9.
A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer.
Eur J Cancer
; 56: 1-9, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26798966
10.
Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors.
Cancer Discov
; 6(7): 740-53, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27217383
11.
Analysis of Overall Survival Benefit of Abemaciclib Plus Fulvestrant in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer-Reply.
JAMA Oncol
; 6(7): 1122-1123, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32463426
Resultados
1 -
11
de 11
1
Próxima >
>>